Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion - Wikidata - wikimedia - TriplyDB

Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion

Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion

http://www.wikidata.org/entity/Q33888845

about

Antiretroviral treatment cohort analysis using time-updated CD4 counts: assessment of bias with different analytic methods Clinical and laboratory characteristics, staging, and outcomes of individuals with AIDS-associated Kaposi's sarcoma at an university hospital Predictive clinical factors in the diagnosis of gastrointestinal Kaposi's sarcoma and its endoscopic severity.Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study Cancer biomarkers in HIV patients The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry.Factors associated with cancer incidence and with all-cause mortality after cancer diagnosis among human immunodeficiency virus-infected persons during the combination antiretroviral therapy era.Nelfinavir impairs glycosylation of herpes simplex virus 1 envelope proteins and blocks virus maturation Metastatic Kaposi's Sarcoma with Perirectal Involvement Diagnosed with Endoscopic Ultrasound-Guided EchoBrush Cytology Sampling.Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.Visceral Kaposi's Sarcoma Presenting as Upper Gastrointestinal Bleeding.A Prospective Study Assessing Tumour Response, Survival, and Palliative Care Outcomes in Patients with HIV-Related Kaposi's Sarcoma at Queen Elizabeth Central Hospital, Blantyre, Malawi.A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa Lichen Planus-like Keratosis: Another Differential Diagnosis for Kaposi Sarcoma Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy Human immunodeficiency virus-associated lung malignancies Burden of Cancers Attributable to Infectious Agents in Nigeria: 2012-2014.Pulmonary Kaposi Sarcoma: An Uncommon Cause of Respiratory Failure in the Era of Highly Active Antiretroviral Therapy-Case Report and Review of the Literature.Kaposi`s sarcoma associated herpesvirus infection among female sex workers and general population women in Shanghai, China: a cross-sectional study.Hepatic Kaposi sarcoma: A case report and review of the literature.Do we still need chemotherapy for AIDS-associated Kaposi's sarcoma?Review of latent and lytic phase biomarkers in Kaposi's sarcoma.Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies.Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort.Comparison of Kaposi sarcoma risk in HIV-positive adults across five continents: a multiregional multicohort study.Adrenal incidentaloma in a patient with HIV/AIDS.Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.Estimating time of HIV-1 infection from next-generation sequence diversity.YGLF motif in the Kaposi sarcoma herpes virus G-protein-coupled receptor adjusts NF-κB activation and paracrine actions.The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era.Prevalence and correlates of Kaposi's sarcoma-associated herpesvirus infection in a sample of men who have sex with men in Eastern China.Survival of patients with Kaposi's sarcoma in the South African antiretroviral treatment era: A retrospective cohort study.[Profile of Kaposi sarcoma patients in the competence network HIV/AIDS].

P2860

Q28478065-F8E44485-6D76-48B0-9A57-E615A44E2EBE Q33675703-1FBE82C8-8D6B-4DD0-B43C-FA9648879253 Q34504929-3420EDE4-7C52-408B-BCB1-601AE4FE9B34 Q34508985-06EEA710-C799-45F5-97F9-009AE5FC3D88 Q34661370-AEFA9282-BAC0-4741-B85B-5901A36EE30F Q34952990-B321B286-1905-4970-B724-99CA7A8FEDFF Q35071910-0A3501E0-ABB7-4433-8275-F20D33EC79CC Q35077455-B2756D37-692C-4E36-B59B-EE587AD00472 Q35149879-AB27F6C3-FE03-4D52-AB28-88784DB14BD7 Q35557475-1FBF5B07-4112-4D00-B9DB-1C3A15819381 Q35625790-09E9191E-7C29-48F1-9E1A-4B96362FA9B7 Q35846173-C87DCAF3-8177-4099-869B-B8E609377295 Q35989731-E7AF1D2E-A7B9-4CCB-8514-22E9BF30B9EC Q36147835-5C85DA84-49A2-4ECC-91D6-94C6B62F352C Q36162341-3F24F86A-4B04-4BB9-838D-CBAFE704FCF1 Q36757480-29ADC6BC-7B52-4BFB-988D-81407D69F83B Q36897143-4A6EC6E8-F361-4D81-9005-52D4458DDC73 Q37359575-64467374-7E22-4466-9947-D190500C0E2B Q37410777-25B69F74-C9DE-4703-810E-485DD46693F1 Q37590921-8E201A08-0A85-4DCD-A399-6CE0FDB2A0C2 Q37628536-0F6B965C-9B33-48B7-9C5E-C4282B32F854 Q38081246-A59EE630-5025-4758-9FF5-C3EE779B5C25 Q38144129-03559EE1-ED72-4A4B-BC2D-230A7CBE1FA5 Q38404819-965C85C6-006D-4D82-A9F1-0BF6DD75217B Q38414729-556BD2D2-88DE-4515-BDAE-4C1F6A8F4A38 Q38771101-88A2D2D8-2E0A-4BE6-96F0-48627FEC7A82 Q40065744-7A74121E-F902-4955-A744-410135B779E1 Q40250347-C5C5102B-D337-4642-8DA1-2289E78C8B7E Q41926717-B0BE029E-116E-47E1-8F1C-5899674CB76A Q42251926-E8333E69-06E5-4E22-931E-229C5E2C0CE4 Q42278556-C1498BAD-A5C8-4D60-8351-A38387E67A0D Q44565603-521182FD-1349-4EB4-AFAB-D88DA1371C98 Q50096998-AF2268CC-931C-4BD0-9940-918E8CFAF82C Q50173084-14BCB764-75BD-45A3-AF8E-AF58DF675615

P2860

Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion

http://www.wikidata.org/entity/Q33888845

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Kaposi sarcoma incidence and s ...... l men after HIV seroconversion

@ast

Kaposi sarcoma incidence and s ...... l men after HIV seroconversion

@en

type

label

Kaposi sarcoma incidence and s ...... l men after HIV seroconversion

@ast

Kaposi sarcoma incidence and s ...... l men after HIV seroconversion

@en

prefLabel

Kaposi sarcoma incidence and s ...... l men after HIV seroconversion

@ast

Kaposi sarcoma incidence and s ...... l men after HIV seroconversion

@en

P1433

Q33888845-F431E3A4-9323-4713-9B34-26687232C975

P1476

Q33888845-92F76D25-7A7F-4268-9A47-E156DFA58C08

P2093

Q33888845-9FD3A305-A1A9-4667-8094-13BDA3436976

Q33888845-C704C5CB-2615-470E-AD62-1429A60458FA

Q33888845-CD0337DE-11D8-40A7-8187-2AFDE21828E2

Q33888845-F2D88461-7FDA-4C59-9037-D2B1810DDEA2

P2860

Q33888845-042A2118-638B-48A2-A75D-55A146AF1578

Q33888845-04687590-9C8D-4FDF-80C5-34425B829C0C

Q33888845-1436864D-6070-4E42-BDC0-0DDE685C473D

Q33888845-159602E3-D9CC-47B3-83E3-0B3ECEE35995

Q33888845-23300A47-5FCA-4B10-BAB9-6F1C4973177D

Q33888845-2A25883C-E998-43A0-8E12-6AA8262E66B4

Q33888845-3F349644-68F3-4973-87A2-E0C29C4B1160

Q33888845-431ACC34-7920-43B2-ABD2-032AB8659374

Q33888845-437AC0AF-DCED-4FB5-B14E-AEC5D7D6FF5D

Q33888845-4930A194-A807-4D0B-873B-7CD9073DC913

P304

Q33888845-55ADA299-FF3F-437F-BEC3-F316AF848F6A

P31

Q33888845-FFF44FAF-34C7-4697-89E6-FFCE95C25603

P356

Q33888845-28F91E5B-C14B-4733-9077-699B65550736

P407

Q33888845-3F28AB83-BAD0-465C-8411-0A832A9E28F0

P433

Q33888845-ECBA0191-3860-4742-B5CF-16942A09C04A

P478

Q33888845-9B7FB5F9-28F4-4266-9224-C762C897E40E

P50

Q33888845-0B232FFB-954C-4D57-B677-425304412F0B

Q33888845-5EB2A5D9-3114-4A83-AEA9-E2632B12BD99

Q33888845-8529A210-BAAE-437F-A899-31012B11A780

P577

Q33888845-D00C1112-983A-4BC0-BD6E-418C9A423D26

P5875

Q33888845-45B7AD22-0875-4359-A179-994464455FE8

P698

Q33888845-A32444CE-E9EE-4DA6-802A-B8A820A153AF

P921

Q33888845-355FFD67-C94B-49CC-B846-A7E36C60390F

P932

Q33888845-FD917DF9-7440-4AF8-903E-63514913EE7F

P356

P1433

Journal of the National Cancer Institute

P1476

Kaposi sarcoma incidence and s ...... l men after HIV seroconversion

@en

P2093

CASCADE Collaboration

http://www.w3.org/2001/XMLSchema#string

Marguerite Guiguet

http://www.w3.org/2001/XMLSchema#string

Martin Fisher

http://www.w3.org/2001/XMLSchema#string

Sara Lodi

http://www.w3.org/2001/XMLSchema#string

P2860

Risk factors for classical Kaposi's sarcoma

Kaposi's sarcoma in homosexual men-a report of eight cases

Raltegravir with optimized background therapy for resistant HIV-1 infection

Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma.

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.

A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma.

AIDS-related cancer and severity of immunosuppression in persons with AIDS.

Changes in the risk of death after HIV seroconversion compared with mortality in the general population.

Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth.

Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks.

P304

784-792

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJQ134

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Dominique Costagliola

P577

2010-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44572930

http://www.w3.org/2001/XMLSchema#string

P698

20442214

http://www.w3.org/2001/XMLSchema#string

P921

P932

2879418

http://www.w3.org/2001/XMLSchema#string